These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1012 related items for PubMed ID: 17446844
1. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis. Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y, Manabe T. Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844 [Abstract] [Full Text] [Related]
2. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Zeng Y, Opeskin K, Goad J, Williams ED. Cancer Res; 2006 Oct 01; 66(19):9566-75. PubMed ID: 17018613 [Abstract] [Full Text] [Related]
3. Low molecular weight heparin suppresses lymphatic endothelial cell proliferation induced by vascular endothelial growth factor C in vitro. Cao G, Wu JX, Wu QH. Chin Med J (Engl); 2009 Jul 05; 122(13):1570-4. PubMed ID: 19719950 [Abstract] [Full Text] [Related]
4. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Kodama M, Kitadai Y, Tanaka M, Kuwai T, Tanaka S, Oue N, Yasui W, Chayama K. Clin Cancer Res; 2008 Nov 15; 14(22):7205-14. PubMed ID: 19010837 [Abstract] [Full Text] [Related]
5. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA. Cancer Res; 2009 Jan 01; 69(1):349-57. PubMed ID: 19118020 [Abstract] [Full Text] [Related]
6. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. Zhang B, Wang J, Gao J, Guo Y, Chen X, Wang B, Gao J, Rao Z, Chen Z. J Cell Biochem; 2009 May 01; 107(1):134-43. PubMed ID: 19241443 [Abstract] [Full Text] [Related]
7. Molecular control of lymphatic metastasis. Achen MG, Stacker SA. Ann N Y Acad Sci; 2008 May 01; 1131():225-34. PubMed ID: 18519975 [Abstract] [Full Text] [Related]
8. Interleukin-1alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer. Tang RF, Wang SX, Zhang FR, Peng L, Wang SX, Xiao Y, Zhang M. Hepatobiliary Pancreat Dis Int; 2005 Aug 01; 4(3):460-3. PubMed ID: 16109537 [Abstract] [Full Text] [Related]
9. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma. Liu B, Ma J, Wang X, Su F, Li X, Yang S, Ma W, Zhang Y. Anat Rec (Hoboken); 2008 Oct 01; 291(10):1227-35. PubMed ID: 18561194 [Abstract] [Full Text] [Related]
10. [Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]. Li K, Li MJ, He T, Zheng Z, Zheng XL, Qu BH, Wang Y, Duan X, Zheng YJ. Zhonghua Yi Xue Za Zhi; 2009 Sep 15; 89(34):2386-90. PubMed ID: 20137690 [Abstract] [Full Text] [Related]
11. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread. Schneider M, Büchler P, Giese N, Giese T, Wilting J, Büchler MW, Friess H. Int J Oncol; 2006 Apr 15; 28(4):883-90. PubMed ID: 16525637 [Abstract] [Full Text] [Related]
12. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO. Cancer Res; 2005 Nov 01; 65(21):9789-98. PubMed ID: 16267000 [Abstract] [Full Text] [Related]
13. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Zeng Y, Opeskin K, Baldwin ME, Horvath LG, Achen MG, Stacker SA, Sutherland RL, Williams ED. Clin Cancer Res; 2004 Aug 01; 10(15):5137-44. PubMed ID: 15297417 [Abstract] [Full Text] [Related]
14. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Bae DG, Kim TD, Li G, Yoon WH, Chae CB. Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646 [Abstract] [Full Text] [Related]
15. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma. Guo B, Zhang Y, Luo G, Li L, Zhang J. Anat Rec (Hoboken); 2009 May 01; 292(5):633-9. PubMed ID: 19382240 [Abstract] [Full Text] [Related]
16. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B. Clin Cancer Res; 2009 Mar 01; 15(5):1741-6. PubMed ID: 19240177 [Abstract] [Full Text] [Related]
17. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer]. Huang JH, Li Y, Liu L, Yang HC, Hai J, Tang LL, Hu TH. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb 01; 31(1):36-9, 51. PubMed ID: 16562672 [Abstract] [Full Text] [Related]
18. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins. Tammela T, He Y, Lyytikkä J, Jeltsch M, Markkanen J, Pajusola K, Ylä-Herttuala S, Alitalo K. Circ Res; 2007 May 25; 100(10):1468-75. PubMed ID: 17478733 [Abstract] [Full Text] [Related]
19. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin. Goldman J, Le TX, Skobe M, Swartz MA. Circ Res; 2005 Jun 10; 96(11):1193-9. PubMed ID: 15890974 [Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Von Marschall Z, Scholz A, Stacker SA, Achen MG, Jackson DG, Alves F, Schirner M, Haberey M, Thierauch KH, Wiedenmann B, Rosewicz S. Int J Oncol; 2005 Sep 10; 27(3):669-79. PubMed ID: 16077915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]